tirzepatide 2.5mg vial Flex-Dose 2 mL Injectable 10 mg/mL Lilly launches lower-price weight-loss drug

Those receiving tirzepatide also had greater reductions in both systolic and diastolic BP compared with placebo

it creates a direct 1:100 scale

Only FDA-approved medications (Mounjaro and Zepbound) are now available for most patients

Contraindications Tirzepatide, whether compounded or brand-name, should not be used by individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, severe gastroparesis or gastrointestinal disease, or during pregnancy

Thicker gauge numbers (lower numbers like 27) are easier to handle but slightly more painful on insertion

Riesenberg BP, Hunt EG, Tennant MD, Hurst KE, Andrews AM, Leddy LR, et al